Human Herpesvirus 8 seroprevalence among blood donors in Mali.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
09 2022
Historique:
revised: 21 02 2022
received: 26 10 2021
accepted: 22 03 2022
pubmed: 14 5 2022
medline: 16 7 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

In sub-Saharan Africa, the Human Herpesvirus 8 (HHV-8) is endemic but with disparities between regions and population studied. Although the virus remains mostly latent, there is some evidence that blood transfusion may represents one of the transmission way for this virus. Here, we evaluated HHV-8 seroprevalence among blood donors in Mali. This cross-sectional study recruited blood donors from the Blood Transfusion Center at Gabriel Touré Hospital, Bamako. Serum was used for the detection of latent HHV-8 immunoglobulin G directed against latent associated nuclear antigen 1 by an indirect immunofluorescence assay. Human immunodeficiency virus 1 (HIV-1), Hepatitis B Virus (HBV), HCV, and Treponema pallidum were also screened. HHV-8 seroprevalence was 10.4% in Malian blood donors. None of the sociodemographic characteristics were associated with HHV-8 infection, although there is a tendency of a higher HHV-8 seroprevalence among participants living in Bamako than those not living there. One individual had coinfection HHV-8/HBV, another HHV-8/HCV while another had HCV and T. pallidum. None has been tested positive for HIV infection. This intermediate seroprevalence in Malian blood donors suggests that the risk of HHV-8 transmission by transfusion should be considered. Further investigations are needed to assess impact of HHV-8 in polytransfused patients residing in an endemic area for this virus.

Identifiants

pubmed: 35546445
doi: 10.1002/jmv.27850
pmc: PMC9283321
mid: NIHMS1807295
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4554-4558

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010350
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):300-8
pubmed: 24296855
J Infect Dis. 2020 Sep 14;222(8):1320-1328
pubmed: 32282911
J Med Virol. 2002 Oct;68(2):164-7
pubmed: 12210403
Int J Cancer. 2010 Nov 15;127(10):2395-401
pubmed: 20143397
Lancet. 1996 Mar 30;347(9005):905
pubmed: 8622424
N Engl J Med. 2006 Sep 28;355(13):1331-8
pubmed: 17005950
Transfusion. 1998 Aug;38(8):771-5
pubmed: 9709786
Int J Infect Dis. 2020 Jun;95:204-209
pubmed: 32294540
J Med Virol. 2006 May;78(5):683-92
pubmed: 16555290

Auteurs

Gervillien Arnold Malonga (GA)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.
Department of Virology and Molecular Oncology, Faculté des Sciences de la Santé, Université Marien NGOUABI, UMNG, Brazzaville, Republic of Congo.

Sidi Dienta (S)

Département de Biologie Médicale, Centre Hospitalier Universitaire Gabriel Touré, Bamako, Mali.

Fatoumata Tata Traore (FT)

Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Zalihatou Maiga (Z)

Département de Biologie Médicale, Centre Hospitalier Universitaire Gabriel Touré, Bamako, Mali.

Alhassane Ba (A)

Centre National de Transfusion Sanguine, Bamako, Mali.

Ousmane Faye (O)

Hôpital de Dermatologie de Bamako, Bamako, Mali.
Faculté de Médecine et d'Odontostomatologie, Bamako, Mali.

Elodie Chicaud (E)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.

Stéphane Marot (S)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.

Vincent Calvez (V)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.

Anne-Geneviève Marcelin (AG)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.

Aude Jary (A)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.

Almoustapha I Maiga (AI)

Département de Biologie Médicale, Centre Hospitalier Universitaire Gabriel Touré, Bamako, Mali.
Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH